News & Videos - MEDTRONIC PLC. - Page 3

New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes PR Newswire DUBLIN and ORLANDO, Fla., June 21, 2024 With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla. , June 21, 2024 /PRNewswire/ -- Medtronic plc (NYSE:...

BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC PR Newswire TROY, Mich., June 14, 2024 TROY, Mich. , June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc . (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use. "With GameStop back in...

Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference PR Newswire DUBLIN, June 7, 2024 DUBLIN , June 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 45th annual Goldman Sachs global healthcare conference on Tuesday, June 11, 2024 . Geoff Martha , Medtronic chairman and chief executive officer, will answer questions on the company beginning at 10:40 a.m. EDT ( 9:40 a.m....

Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference PR Newswire DUBLIN, June 6, 2024 DUBLIN , June 6 , 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 45th annual Goldman Sachs global healthcare conference on Tuesday, June 11, 2024 . Geoff Martha , Medtronic chairman and chief executive officer, will answer questions on the company beginning at 10:40 a.m. EDT ( 9:40 a.m....

Medtronic announces closing of public offering of €3.0 billion of senior notes PR Newswire DUBLIN, June 3, 2024 DUBLIN , June 3, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of...

Medtronic announces closing of public offering of €3.0 billion of senior notes PR Newswire DUBLIN, June 3, 2024 DUBLIN , June 3, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of...

Medtronic announces pricing of €3.0 billion of senior notes PR Newswire DUBLIN, May 30, 2024 DUBLIN , May 30, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and...

Medtronic announces pricing of €3.0 billion of senior notes PR Newswire DUBLIN, May 29, 2024 DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and...

Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase PR Newswire DUBLIN, May 23, 2024 Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles across many high-growth markets DUBLIN , May 23, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter (Q4) and...

Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase PR Newswire DUBLIN, May 23, 2024 Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles across many high-growth markets DUBLIN , May 23, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter (Q4) and...

MiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas PR Newswire DUBLIN, May 20, 2024 Award recognizes the commitment of Medtronic to revolutionizing diabetes care DUBLIN , May 20, 2024 /PRNewswire/ -- Fast Company announced that the Medtronic MiniMed™ 780G automated insulin delivery system has been recognized in the Best World-Changing Idea, North America category as part of the 2024 World Changing Ideas Awards. Fast Company's annual World Changing Ideas list...

MiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas PR Newswire DUBLIN, May 20, 2024 Award recognizes the commitment of Medtronic to revolutionizing diabetes care DUBLIN , May 20 , 2024 /PRNewswire/ -- Fast Company announced that the Medtronic MiniMed™ 780G automated insulin delivery system has been recognized in the Best World-Changing Idea, North America category as part of the 2024 World Changing Ideas Awards. Fast Company's annual World Changing Ideas list...

Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment PR Newswire DUBLIN and BOSTON, May 18, 2024 HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 18, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in...

Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment PR Newswire DUBLIN and BOSTON, May 17, 2024 HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON , May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in...

Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™ PR Newswire DUBLIN and BOSTON, May 17, 2024 Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON , May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead...

Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™ PR Newswire DUBLIN and BOSTON, May 17, 2024 Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON , May 17, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead...

Medtronic to announce financial results for its fourth quarter and full fiscal year 2024 PR Newswire DUBLIN, May 9, 2024 DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com . The...

Medtronic to announce financial results for its fourth quarter and full fiscal year 2024 PR Newswire DUBLIN, May 9, 2024 DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com . The...

Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator PR Newswire DUBLIN, April 26, 2024 Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of...

Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator PR Newswire DUBLIN, April 26, 2024 Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of...